<DOC>
	<DOCNO>NCT01775865</DOCNO>
	<brief_summary>Cardiovascular disease ( CVD ) lead cause morbidity mortality United States old age primary risk factor . The number adult great age 65 year almost double 70 million 2030 , therefore identify therapeutic strategy treat prevent age-related disorder human major biomedical importance . Cardiovascular aging , define reduction vascular cardiac function normal age , occurs even absence CVD risk factor overt CVD . A key feature cardiovascular age stiffen large elastic central artery aorta ( large blood vessel leave heart supply blood body ) . This important aortic stiffness directly contribute clinical problem increase blood pressure , reduce blood flow heart muscle , thicken heart muscle . Therefore , clinical consequence hypothesize mediate substantial proportion increase CVD risk older adult . However , effective drug treatment aortic stiffness currently available biological reason ( mechanism ) involve cause aortic stiffening remain undefined . In addition , inability small blood vessel relax , impairment heart relax fill phase heart cycle ( i.e. , diastole ) , increase blood pressure variability ( fluctuation blood pressure day ) , link aortic stiffness . Furthermore , chronic low-grade inflammation advance age propose common mechanistic link ( i.e. , biological reason ) reduction cardiovascular function old adult . Therefore , investigator propose inflammation could novel therapeutic target treat cardiovascular age old adult . Our central hypothesis inflammation mediate age-related deterioration cardiovascular function observe advance age development oxidative stress ( i.e. , imbalance cellular production damage oxygen free radical vs. protective antioxidant ) . Our hypothesis predict chronic inhibition inflammation Salsalate , FDA-approved anti-inflammatory drug similar aspirin typically use treat rheumatoid arthritis pain know inhibit 'master ' regulator inflammation cell ( i.e. , nuclear factor kappa B ) , improve cardiovascular function old adult . In addition , investigator hypothesize mechanism improvement cardiovascular function inhibition inflammation suppress oxidative stress . To test hypothesis , investigator randomize old healthy adult ( age 50-79 year ) 3 g/day salsalate placebo ( i.e. , pill inactive substance ) pills 4 week cardiovascular function measure baseline 4 week .</brief_summary>
	<brief_title>Targeting Inflammation Treat Cardiovascular Aging</brief_title>
	<detailed_description>Aim 1 : To measure aortic wall stiffness circulate biomarkers oxidative stress acute ( IV ) intravenous infusion saline antioxidant vitamin C baseline 4 week salsalate placebo healthy old adult . Hypothesis 1 : Inhibition inflammation old adult decrease aortic wall stiffness part reduction oxidative stress . Aim 2 : To measure brachial artery endothelium-dependent vasodilation ( EDV ) circulate marker oxidative stress acute intravenous infusion saline vitamin C baseline 4 week salsalate placebo healthy old adult . Hypothesis 2 : Inhibition inflammation old adult improve vascular endothelial vasodilatory function old adult part reduction oxidative stress . Aim 3 : To measure leave ventricular ( LV ) diastolic relaxation fill dynamic circulate marker oxidative stress acute intravenous infusion saline vitamin C baseline 4 week Salsalate placebo healthy old adult . Hypothesis 3 : Inhibition inflammation old adult improve LV diastolic function part reduction oxidative stress . Exploratory Aim : To measure 24-hour pressure variability short-term baroreflex sensitivity 4 week oral Salsalate placebo treatment old adult . Exploratory hypothesis : Inhibition inflammation old adult improve cardiovascular autonomic dysregulation old healthy adult .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>Willing able provide write , sign informed consent nature study explain , prior researchrelated procedure . Age &gt; = 50 &lt; = 79 year ( old ) &gt; = 18 &lt; = 39 year age healthy , determined health history questionnaire , medical history physical examination physician nurse practitioner , blood urine chemistry , rest blood pressure exercise 12lead ECG blood chemistry indicative normal renal ( creatinine &lt; 2.2 mg/dl ) , normal liver , i.e. , &lt; 3 time upper limit alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) , thyroid function ( TSH 0.4 5.0 mU/L ) If currently receive treatment take follow supplement , willing able discontinue take 2 week prior throughout treatment period : Vitamin C , E multivitamins contain vitamin C E ; nutraceuticals contain vitamin C E No history cardiovascular disease ( e.g. , heart attack , stroke , heart failure , valvular heart disease , cardiomyopathy ) , Type 2 diabetes , chronic obstructive pulmonary peripheral arterial disease Middleaged/older females postmenopausal least 1 year , tubal ligation least 1 year prior screening , total hysterectomy . Sedentary recreationally active define performs regular aerobic exercise ( 30 min vigorous walking , jogging , swimming , cycling , etc ) less 3 days/week less 12 days/month last year Nonsmokers , define history smoking , smoke least past 1 year Normal rest 12lead ECG . History cardiovascular disease heart angioplasty/stent bypass surgery , myocardial infarction , stroke , heart failure without LV ejection fraction &lt; 40 % , cardiomyopathy , valvular heart disease , cardiomyopathy , heart transplantation , Type 2 diabetes Type 1 diabetes Smoking history smoking within past one year History gastric ulcer , bleed disorder , dyspepsia , severe gastroesophageal reflux disease ( GERD ) , metabolic acidosis History asthma lung disease ( chronic obstructive pulmonary disease , COPD ) Abnormal rest 12lead ECG ( e.g. , evidence myocardial infarction , leave ventricular hypertrophy , leftbundle branch block , 2nd 3rd degree atrioventricular ( AV ) block , atrial fibrillation/flutter ) Serious neurologic disorder include seizure History renal failure , dialysis kidney transplant Serum creatinine &gt; 2.2 mg/dL , hepatic enzyme concentration &gt; 3 time upper limit normal History HIV infection , hepatic cirrhosis , preexist liver disease , positive HIV , Hepatitis B C test screening . Use investigational product investigational medical device within 30 day prior screen , requirement investigational agent prior completion schedule study assessment . History recent chicken pox , shingle influenza ( ie. , risk Reye 's syndrome ) Recent flulike symptom within past 2 week Pregnant breastfeed screening , plan become pregnant ( self partner ) time study . A urinary pregnancy test do female . If test positive , subject exclude . Women history hormone replacement therapy within past 6 month History rheumatoid arthritis , Grave 's disease , systemic lupus erythematosis , Wegener 's granulomatosis ; Taking medication diabetes mellitus , kidney disease , liver disease , asthma , sepsis seizure disorder ; Taking lipid lowering ( e.g. , statin , niacin ) , glycemic control ( e.g . metformin , insulin ) , anticoagulation , antiseizure , antidepression antipsychotic agent History comorbid condition would limit life expectancy &lt; 6 month . It unknown Salsalate transfer seminal fluid men . However , recommend proper protection condom use intercourse study . Concomitant treatment : aspirin , baby aspirin , indomethacin , naproxen ( Aleve ) , acetaminophen ( Tylenol ) , ibuprofen ( Advil , Motrin ) , nonsteroidal antiinflammatory drug ; cox2 inhibitor ( Celebrex , Vioxx , etc ) ; allopurinol ( Zyloprim , Lopurin , Allopurin ; coumadin ( Warfarin ) , enoxaparin ( Lovenox ) ; clopidogrel ( Plavix ) ; dipyridamole ( Persantine ) ; heparin ; diabetic medication ( Metformin , glyburide , insulin , etc ) , thiazolidinediones ( Avandia , Rezulin , Actos ) ; corticosteroid ( prednisone ) ; methotrexate , infliximab ( Remicade ) , etanercept ( Enbrel ) ; levothyroxine ( Levoxyl , Synthroid , Levoxyl , Unithroid ) ; Levodopa ; Phosphodiesterase ( PDE ) 5 inhibitor ( e.g. , Viagra速 , Cialis速 , Levitra速 , Revatio速 ) ; PDE 3 inhibitor ( e.g. , cilostazol , milrinone , vesnarinone ) ; lithium May participate use follow medication discontinue 2 week prior participation : salicylate medication , aspirin , antioxidant , herbal supplement , vitamin , omega3 fatty acid ; cox2 inhibitor ( Celebrex , Vioxx , etc ) May participate use follow medication 48 hour prior experimental visit : naproxen ( Aleve ) , acetaminophen ( Tylenol ) , ibuprofen ( Advil , Motrin ) , nonsteroidal antiinflammatory drug Vulnerable population ( prisoner , etc . ) include study study healthy middleaged/older adult . Any condition , view PI , place subject high risk poor treatment compliance complete study . Hemoglobin &lt; 12 mg/dl men ; &lt; 10 mg/dl woman History alcohol abuse &gt; 10 alcoholic unit per week ( 1 unit= 1 beer , 1 glass wine , 1 mixed cocktail contain 1 oz alcohol ) Low platelet ( &lt; 100,000 cu mm ) On weight loss drug ( e.g. , Xenical ( orlistat ) , Meridia ( sibutramine ) , Acutrim ( phenylpropanolamine ) , similar overthecounter medication ) within 3 month screen Any surgery within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>aortic stiffness</keyword>
	<keyword>endothelium-dependent dilation</keyword>
	<keyword>vascular age</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>inflammation</keyword>
	<keyword>nitric oxide</keyword>
	<keyword>nuclear factor kappa B</keyword>
</DOC>